ArticleAPSIPA Transactions on Signal and Information Processing2026
Individualized Treatment Effect Inference of Head and Neck Cancer with Multimodal Data.
Article in APSIPA Transactions on Signal and Information Processing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Estimating individualized treatment effects (ITE) is critical for personalized medicine, yet it remains a challenge due to retrospective observational data, which suffer from selection bias in clinical practice, and the complexity of multimodal data used for patient status depiction. In this work, we develop an end-to-end deep learning (DL) framework that incorporates multimodal patient data and multiple treatments for accurate ITE inference in a retrospective head and neck cancer (HNC) study. A possible solution is concatenating the factors and adapt adversarial training, which has shown great promise on tabular data, to disentangle patient characteristics from patient status features to mitigate treatment selection bias. However, this approach suffers from instability when applied to complex multimodal patient data and multiple treatment options. For flexible and efficient, treatment-conditioned information fusion, we propose a bi-stage adaptive instance normalization (Bi-AdaIN) to inject relevant factors into corresponding layers, an approach that is also robust to missing values. Furthermore, we propose to disentangle status features from the multi-treatment variable using mutual information (MI) regularization, enabling more accurate predictions of patient-specific outcomes for both factual and counterfactual data. We evaluated our model on the RADCURE dataset, comprising 3,346 HNC cases with CT scans and multiple clinical variables who received radiotherapy or additional chemotherapy and EGFRI. The Bias-Adjusted Treatment Effect (BATE) is substantially reduced compared to the conventional direct ITE method (which does not consider treatment bias) and to adversarial training, indicating a more robust estimation of causal effects. This work is one of the first DL-based studies to address ITE estimation using multimodal medical imaging, offering a promising approach to counterfactual reasoning in clinical oncology for decision support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.